Attention Deficit Hyperactivity Disorder (ADHD)
Conditions
Brief summary
Subjects will answer the following questionnaire and tests: * Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS) * Demographic Questionnaire - composed by the researchers * Family Eating Habits Questionnaire (FEAHQ-33) * Food Frequency Questionnaire (FFQ) * Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Detailed description
Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age. Subjects will answer the following questionnaire and tests: * Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS) * Demographic Questionnaire - composed by the researchers * Family Eating Habits Questionnaire (FEAHQ-33) * Food Frequency Questionnaire (FFQ) * Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Interventions
DIETARY_SUPPLEMENTProbiotic
Probiotic
DIETARY_SUPPLEMENTPlacebo
Probiotics capsules without the active ingredient
Sponsors
Tel Hai College
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
19 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
* Students registered in the college's Support Center for Students with Learning Disabilities and who have been diagnosed by a computerized didactic assessment -MATAL - as well as an attention diagnosis by a psychiatrist or a neurologist, * Students who are not treated by medication or alternative treatment, * Students who are not due to complete their education at Tel Hai College during the study period, * Students who have signed on an informed consent form, * No dairy intolerance (student can consume milk without any adverse effects), * No soy allergy, * Not currently taking any antibiotics or probiotics, * Not pregnant or planning to become pregnant during the study period, * Not been diagnosed with any of the following: * Cancer * HIV/AIDS * Crohn's disease * Ulcerative colitis * Immune compromised illness * Other serious illness
Exclusion criteria
* Students treated by any type of treatment for Attention Deficit Hyperactivity Disorder, * Students who have not been assessed by MATAL and a psychiatrist, * Students who take antibiotics.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduce symptoms of attention deficit measured by MOXO test | Six month | After six month of treatment reduce symptoms of attention deficit will be measured by MOXO test |
Outcome results
None listed